Log in to save to my catalogue

Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study

Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8369783cc437428cb37391415363f5bd

Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study

About this item

Full title

Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2023-01, Vol.12 (1), p.368-378

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
Mesenchymal chondrosarcoma (MCS) is an ultra‐rare sarcoma that follows a more aggressive course than conventional chondrosarcoma. This study evaluates prognostic factors, treatments (surgery, chemotherapy, and radiation), and outcomes in an Australian setting.
Methods
We collected demographics, clinicopathological variables, tre...

Alternative Titles

Full title

Mesenchymal chondrosarcoma: An Australian multi‐centre cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8369783cc437428cb37391415363f5bd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8369783cc437428cb37391415363f5bd

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.4849

How to access this item